CompanyGRCENasdaqPrinceton, NJ

Grace Therapeutics Inc.

Grace Therapeutics develops IV infusion drug delivery technologies for rare and orphan diseases.

SEC EDGAR ClinicalTrials.gov gracetx.com

8-KSep 18Latest SEC filing, period to Sep 17

Aug 13Latest story

August 2026

Grace Therapeutics details GTx-104 resubmission plan after CRL, sets cash runway to 2028

Aug 13Quarterly updateGrace Therapeutics Inc.

Grace Therapeutics raises $10 million in private placement for GTx-104

Aug 10FinancingGrace Therapeutics Inc.